BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 136 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,947,600 | +0.6% | 1,970,000 | 0.0% | 0.25% | +7.3% |
| Q2 2023 | $13,868,800 | +50.8% | 1,970,000 | +78.6% | 0.23% | +38.5% |
| Q1 2023 | $9,198,094 | +8.9% | 1,102,889 | +5.3% | 0.17% | -54.8% |
| Q4 2018 | $8,449,000 | +5.8% | 1,047,000 | 0.0% | 0.37% | +27.6% |
| Q3 2018 | $7,989,000 | +461.0% | 1,047,000 | +261.0% | 0.29% | +295.9% |
| Q4 2017 | $1,424,000 | -6.3% | 290,000 | 0.0% | 0.07% | -14.0% |
| Q3 2017 | $1,520,000 | -5.7% | 290,000 | 0.0% | 0.09% | -14.0% |
| Q2 2017 | $1,612,000 | – | 290,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |